OVID
Ovid Therapeutics Inc.
Company overview
- Market capitalization
- $480.43M
- Employees
- 23
- Latest publication
- 2026-09-29
About Ovid Therapeutics Inc.
Ovid Therapeutics Inc., a biopharmaceutical company, engages in the development of small molecule medicines for brain disorders including epilepsies and seizure-related neurological disorders in the United States. The company is developing OV329, a GABA-AT inhibitor which is in Phase 1 clinical trials for the treatment of adult and infant drug-resistant epilepsies; and OV4071, a first-in-human oral potassium-chloride cotransporter 2 direct activator which is in Phase 1 clinical trials for the treatment of psychosis associated with parkinson's disease, lewy body dementia, and acute schizophrenia. It has license and collaboration agreements with AstraZeneca AB, H. Lundbeck A/S, Northwestern University, and Graviton, as well as Marinus Pharmaceuticals, Inc. The company was incorporated in 2014 and is headquartered in New York, New York.
Financial statements
Income Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 733,000USD | 0USD | 718,000USD | 132,000USD | 6,272,000USD | 130,000USD | 76,000USD | 173,000USD |
| Research Development | 9,957,000USD | 11,146,000USD | 6,589,000USD | 5,870,000USD | 6,465,000USD | 6,659,000USD | 5,923,000USD | 7,855,000USD |
| Selling General Administrative | 6,474,000USD | 6,665,000USD | 6,422,000USD | 6,785,000USD | 4,880,000USD | 6,021,000USD | 6,775,000USD | 5,544,000USD |
| General And Administrative Expenses | 6,474,000USD | — | — | — | — | — | — | — |
| Total Operating Expenses | 16,431,000USD | 17,811,000USD | 13,011,000USD | 12,655,000USD | 11,345,000USD | 12,680,000USD | 10,798,000USD | 13,399,000USD |
| Operating Income | -15,698,000USD | -17,846,000USD | -12,293,000USD | -12,523,000USD | -5,073,000USD | -12,550,000USD | -10,722,000USD | -13,226,000USD |
| Total Other Income Expense Net | 689,000USD | 858,000USD | 21,956,000USD | 365,000USD | 389,000USD | 2,315,000USD | 1,469,000USD | -780,000USD |
| Interest Income | 1,558,000USD | — | — | — | — | — | — | — |
| Income Before Tax | -15,009,000USD | -16,988,000USD | 9,663,000USD | -12,158,000USD | -4,684,000USD | -10,235,000USD | -9,253,000USD | -14,006,000USD |
| Income Tax Expense | 0USD | — | — | — | — | — | — | — |
| Net Income | -15,009,000USD | -16,988,000USD | 9,663,000USD | -12,158,000USD | -4,684,000USD | -10,235,000USD | -9,253,000USD | -14,006,000USD |
| Cost Of Revenue | — | 35,000USD | 44,000USD | 17,000USD | 99,000USD | 284,000USD | — | 169,000USD |
| Gross Profit | — | -35,000USD | 718,000USD | 132,000USD | 6,272,000USD | 130,000USD | 76,000USD | 173,000USD |
| Tax Provision | — | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD |
| Net Income From Continuing Ops | — | -16,988,000USD | 9,663,000USD | -12,158,000USD | -4,684,000USD | -10,235,000USD | -9,253,000USD | -14,006,000USD |
| Ebit | — | -17,846,000USD | -12,293,000USD | -12,523,000USD | -5,073,000USD | -12,550,000USD | -10,922,000USD | -13,226,000USD |
| Ebitda | — | -17,811,000USD | -12,276,000USD | -12,507,000USD | -4,974,000USD | -12,409,000USD | -10,762,000USD | -13,057,000USD |
| Depreciation And Amortization | — | 35,000USD | 17,000USD | 16,000USD | 99,000USD | 141,000USD | 160,000USD | 169,000USD |
| Reconciled Depreciation | — | 35,000USD | 17,000USD | 16,000USD | 99,000USD | 141,000USD | 160,000USD | 169,000USD |
| Selling And Marketing Expenses | — | — | — | — | — | 29,000USD | — | — |
| Unclassified Operating Expenses | — | — | — | — | — | — | -1,900,000USD | — |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 7,252,000USD | 566,000USD | 392,000USD | 1,502,748USD | 208,382,779USD | 12,617,221USD | 0USD | 0USD |
| Cost Of Revenue | 300,000USD | 600,000USD | 1,597,000USD | 1,381,606USD | — | — | 255,000USD | 141,733USD |
| Gross Profit | 6,952,000USD | 566,000USD | 392,000USD | 1,502,748USD | 208,382,779USD | 12,617,221USD | -255,000USD | -141,733USD |
| Research Development | 25,582,000USD | 36,767,000USD | 28,588,000USD | 24,618,399USD | 46,939,583USD | 63,417,394USD | 42,157,641USD | 33,790,031USD |
| Selling General Administrative | 24,109,000USD | 25,683,000USD | 29,585,000USD | 32,432,510USD | 37,233,000USD | 30,630,804USD | 19,251,826USD | 19,141,652USD |
| Total Operating Expenses | 49,391,000USD | 62,451,000USD | 59,673,000USD | 57,050,909USD | 84,173,687USD | 94,048,198USD | 61,409,467USD | 52,931,683USD |
| Operating Income | -42,439,000USD | -61,885,000USD | -59,281,000USD | -55,548,161USD | 124,209,092USD | -81,430,977USD | -61,409,467USD | -52,931,683USD |
| Income Before Tax | -17,414,000USD | -26,433,000USD | -52,339,000USD | -54,169,029USD | 124,163,402USD | -81,035,576USD | -60,461,243USD | -51,979,610USD |
| Tax Provision | 0USD | 0USD | 0USD | -349,714USD | 1,328,818USD | 0USD | — | — |
| Net Income | -17,414,000USD | -26,433,000USD | -52,339,000USD | -51,408,292USD | 122,834,584USD | -80,728,728USD | -59,258,017USD | -51,979,610USD |
| Net Income From Continuing Ops | -17,414,000USD | -26,433,000USD | -48,521,714USD | -54,169,029USD | 122,834,584USD | -81,035,576USD | -60,461,243USD | -51,979,610USD |
| Ebit | -42,439,000USD | -58,385,000USD | -57,581,000USD | -55,548,161USD | 124,210,196USD | -81,430,977USD | -61,409,467USD | -52,931,683USD |
| Ebitda | -42,139,000USD | -57,772,000USD | -57,013,000USD | -54,166,556USD | 124,447,275USD | -81,124,129USD | -61,154,465USD | -52,789,950USD |
| Depreciation And Amortization | 300,000USD | 613,000USD | 568,000USD | 1,381,605USD | 237,079USD | 306,848USD | 255,002USD | 141,733USD |
| Reconciled Depreciation | 273,000USD | 613,000USD | 1,635,133USD | 1,381,605USD | 237,079USD | 306,848USD | 255,002USD | 141,733USD |
| Total Other Income Expense Net | 25,025,000USD | 35,452,000USD | 6,942,000USD | 1,379,132USD | -45,690USD | 395,401USD | 948,224USD | 951,725USD |
| Interest Income | — | 3,900,000USD | 4,900,000USD | — | — | — | 948,224USD | 952,073USD |
| Net Interest Income | — | 3,900,000USD | 4,900,000USD | — | — | — | 948,224USD | 952,073USD |
| Selling And Marketing Expenses | — | — | 726USD | — | — | — | — | — |
| Unclassified Operating Expenses | — | — | 1,499,274USD | — | — | — | — | — |
| Income Tax Expense | — | — | 5USD | -2,760,737USD | 1,328,818USD | -306,848USD | -1,203,226USD | 951,725USD |
| Interest Expense | — | — | — | 2,760,737USD | 46,794USD | 0USD | 0USD | 0USD |
| Non Operating Income Net Other | — | — | — | 1,379,132USD | — | — | 948,224USD | 952,073USD |
| Net Income Applicable To Common Shares | — | — | — | -54,169,029USD | 119,839,261USD | -81,035,576USD | -60,461,243USD | -51,979,610USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 231,973,000USD | 225,628,000USD | 150,934,000USD | 63,848,000USD | 77,428,000USD | 81,654,000USD | 92,167,000USD | 102,654,000USD |
| Cash And Equivalents | 11,327,000USD | — | — | — | — | — | — | — |
| Total Current Assets | 123,617,000USD | 160,145,000USD | 90,447,000USD | 28,824,000USD | 42,089,000USD | 45,921,000USD | 55,940,000USD | 65,827,000USD |
| Other Current Assets | 6,398,000USD | 4,623,000USD | 20,812,000USD | 3,221,000USD | 3,742,000USD | 2,925,000USD | 2,865,000USD | 3,115,000USD |
| Total Liabilities | 22,083,000USD | — | — | — | — | — | — | — |
| Total Current Liabilities | 9,980,000USD | 15,748,000USD | 8,288,000USD | 6,796,000USD | 8,924,000USD | 9,307,000USD | 10,522,000USD | 11,630,000USD |
| Other Current Liabilities | 4,424,000USD | — | — | — | — | — | — | — |
| Total Stockholder Equity | 209,890,000USD | 198,269,000USD | 130,660,000USD | 44,698,000USD | 55,789,000USD | 59,276,000USD | 68,226,000USD | 76,290,000USD |
| Total Equity Including Noncontrolling Interest | 209,890,000USD | — | — | — | — | — | — | — |
| Property Plant Equipment Net | 11,181,000USD | 11,515,000USD | 11,862,000USD | 12,185,000USD | 12,500,000USD | 12,855,000USD | 13,230,000USD | 13,589,000USD |
| Accounts Payable | 4,072,000USD | 8,876,000USD | 1,956,000USD | 1,710,000USD | 3,950,000USD | 1,950,000USD | 3,191,000USD | 2,710,000USD |
| Short Term Debt | 1,484,000USD | 1,459,000USD | 1,433,000USD | 1,409,000USD | 1,384,000USD | 1,360,000USD | 1,336,000USD | 1,313,000USD |
| Common Stock | 185,000USD | 167,000USD | 130,000USD | 71,000USD | 71,000USD | 71,000USD | 71,000USD | 71,000USD |
| Retained Earnings | -353,710,000USD | -338,701,000USD | -321,713,000USD | -331,376,000USD | -319,218,000USD | -314,533,000USD | -304,299,000USD | -295,045,000USD |
| Accumulated Other Comprehensive Income | -750,000USD | -422,000USD | -202,000USD | -126,000USD | -69,000USD | -48,000USD | -35,000USD | 36,000USD |
| Total Liab | — | 27,359,000USD | 20,274,000USD | 19,150,000USD | 21,639,000USD | 22,378,000USD | 23,941,000USD | 26,364,000USD |
| Other Current Liab | — | 5,413,000USD | 4,899,000USD | 2,959,000USD | 3,590,000USD | 5,997,000USD | 5,995,000USD | 7,607,000USD |
| Capital Stock | — | 167,000USD | 130,000USD | 71,000USD | 71,000USD | 71,000USD | 71,000USD | 71,000USD |
| Cash | — | 94,064,000USD | 13,153,000USD | 20,611,000USD | 28,415,000USD | 21,136,000USD | 26,301,000USD | 15,017,000USD |
| Cash And Short Term Investments | — | 155,522,000USD | 69,635,000USD | 25,603,000USD | 38,347,000USD | 42,996,000USD | 53,075,000USD | 62,712,000USD |
| Net Debt | — | -92,605,000USD | 266,000USD | -6,848,000USD | -14,316,000USD | -6,706,000USD | -11,546,000USD | 58,000USD |
| Short Long Term Debt Total | — | 1,459,000USD | 13,419,000USD | 13,763,000USD | 14,099,000USD | 14,430,000USD | 14,755,000USD | 15,075,000USD |
| Long Term Investments | — | 52,037,000USD | 62,773,000USD | 20,908,000USD | 20,908,000USD | 20,908,000USD | 20,974,000USD | 21,125,000USD |
| Short Term Investments | — | 61,458,000USD | 56,482,000USD | 4,992,000USD | 9,932,000USD | 21,860,000USD | 26,774,000USD | 47,695,000USD |
| Property Plant Equipment Gross | — | 13,138,000USD | 13,450,000USD | 13,756,000USD | 14,055,000USD | 14,349,000USD | 14,637,000USD | 14,899,000USD |
| Common Stock Shares Outstanding | — | 73,735,606shares | 81,671,581shares | 71,109,514shares | 71,109,514shares | 71,045,000shares | 71,010,000shares | 70,976,000shares |
| Non Current Assets Total | — | 65,483,000USD | 60,487,000USD | 35,024,000USD | 35,339,000USD | 35,733,000USD | 36,227,000USD | 36,827,000USD |
| Non Current Liabilities Total | — | 11,611,000USD | 11,986,000USD | 12,354,000USD | 12,715,000USD | 13,071,000USD | 13,419,000USD | 14,734,000USD |
| Non Currrent Assets Other | — | 12,007,000USD | -4,216,999USD | 1,931,000USD | 1,931,000USD | 1,932,000USD | 1,931,000USD | 1,958,000USD |
| Net Working Capital | — | 144,397,000USD | 66,080,000USD | 22,028,000USD | 33,165,000USD | 36,614,000USD | 45,418,000USD | 54,197,000USD |
| Unclassified Non Current Assets | — | -10,076,000USD | -14,148,000USD | — | — | — | — | — |
| Unclassified Non Current Liabilities | — | 11,611,000USD | 11,986,000USD | 12,354,000USD | 12,715,000USD | 13,071,000USD | 13,419,000USD | 13,762,000USD |
| Unclassified Equity | — | 537,058,000USD | 452,315,000USD | 376,058,000USD | 374,934,000USD | 373,715,000USD | 372,418,000USD | 371,157,000USD |
| Current Deferred Revenue | — | — | — | 718,000USD | 718,000USD | — | — | — |
| Intangible Assets | — | — | — | — | — | 38,000USD | 92,000USD | 155,000USD |
| Non Current Liabilities Other | — | — | — | — | — | — | — | 972,000USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 150,934,000USD | 92,167,000USD | 144,027,000USD | 155,265,814USD | 194,544,757USD | 75,925,518USD | 80,843,731USD | 47,649,602USD |
| Other Current Assets | 20,812,000USD | 2,865,000USD | 3,764,000USD | 2,379,281USD | 2,681,597USD | 2,667,508USD | 1,942,933USD | 2,767,495USD |
| Total Liab | 20,274,000USD | 23,941,000USD | 56,230,000USD | 22,993,251USD | 14,798,321USD | 32,293,862USD | 10,820,170USD | 8,844,457USD |
| Total Stockholder Equity | 130,660,000USD | 68,226,000USD | 87,797,000USD | 132,272,563USD | 179,746,436USD | 43,631,656USD | 70,023,561USD | 38,805,145USD |
| Other Current Liab | 4,899,000USD | 5,995,000USD | 6,524,000USD | 4,504,669USD | 7,671,275USD | 14,403,677USD | 7,277,510USD | 5,088,862USD |
| Common Stock | 130,000USD | 71,000USD | 71,000USD | 70,467USD | 70,359USD | 65,743USD | 54,711USD | 24,654USD |
| Capital Stock | 130,000USD | 71,000USD | 70,693USD | 70,468USD | 70,360USD | 65,746USD | 54,719USD | 24,654USD |
| Retained Earnings | -321,713,000USD | -304,299,000USD | -277,865,000USD | -225,526,542USD | -171,357,513USD | -294,192,097USD | -213,156,521USD | -152,695,278USD |
| Cash | 13,153,000USD | 26,301,000USD | 27,042,000USD | 44,867,846USD | 187,797,532USD | 72,033,930USD | 41,897,144USD | 36,489,618USD |
| Cash And Short Term Investments | 69,635,000USD | 53,075,000USD | 105,834,000USD | 129,001,410USD | 187,797,532USD | 72,033,930USD | 76,739,113USD | 41,500,652USD |
| Total Current Assets | 90,447,000USD | 55,940,000USD | 109,598,000USD | 131,380,691USD | 190,479,129USD | 74,843,201USD | 79,813,192USD | 44,268,147USD |
| Total Current Liabilities | 8,288,000USD | 10,522,000USD | 11,473,000USD | 6,991,525USD | 14,798,321USD | 22,062,775USD | 10,533,608USD | 8,844,457USD |
| Net Debt | 266,000USD | -11,546,000USD | -11,040,000USD | -28,332,175USD | -187,797,532USD | -72,033,930USD | -41,897,144USD | -36,489,618USD |
| Short Term Debt | 1,433,000USD | 1,336,000USD | 1,246,000USD | 533,946USD | — | — | — | — |
| Short Long Term Debt Total | 13,419,000USD | 14,755,000USD | 16,002,000USD | 16,535,671USD | — | — | — | — |
| Long Term Investments | 62,773,000USD | 20,974,000USD | 17,625,620USD | 5,622,547USD | 1,631,992USD | 0USD | — | — |
| Short Term Investments | 56,482,000USD | 26,774,000USD | 78,792,000USD | 84,133,565USD | 0USD | 0USD | 34,841,969USD | 5,011,034USD |
| Accounts Payable | 1,956,000USD | 3,191,000USD | 3,703,000USD | 1,952,910USD | 7,127,046USD | 5,446,206USD | 3,256,098USD | 3,755,595USD |
| Property Plant Equipment Net | 11,862,000USD | 13,230,000USD | 14,663,000USD | 16,070,632USD | 242,757USD | 135,620USD | 68,363USD | 69,867USD |
| Property Plant Equipment Gross | 13,450,000USD | 14,637,000USD | 15,664,028USD | 16,652,013USD | 504,965USD | 135,620USD | 68,363USD | 69,867USD |
| Accumulated Other Comprehensive Income | -202,000USD | -35,000USD | 702USD | -42,187USD | — | — | 2,469USD | -1,829USD |
| Common Stock Shares Outstanding | 73,735,606shares | 70,905,000shares | 70,581,000shares | 70,425,000shares | 68,068,000shares | 58,451,000shares | 39,217,000shares | 24,631,000shares |
| Non Current Assets Total | 60,487,000USD | 36,227,000USD | 34,429,000USD | 23,885,123USD | 4,065,628USD | 1,082,417USD | 1,030,539USD | 3,381,455USD |
| Non Current Liabilities Total | 11,986,000USD | 13,419,000USD | 44,757,000USD | 16,001,726USD | 7,127,046USD | 10,231,087USD | 286,562USD | 0USD |
| Non Currrent Assets Other | -4,216,999USD | 1,931,000USD | 1,940,000USD | 1,969,844USD | 96,126USD | 627,797USD | 495,176USD | 2,919,716USD |
| Net Working Capital | 66,080,000USD | 45,418,000USD | 98,123,417USD | 124,389,166USD | 175,680,808USD | 52,780,426USD | 69,279,584USD | 35,423,690USD |
| Unclassified Non Current Assets | -14,148,000USD | — | — | -1,930,753USD | — | — | — | -2,919,716USD |
| Unclassified Non Current Liabilities | 11,986,000USD | 13,419,000USD | 14,757,000USD | 16,001,726USD | 7,127,046USD | -10,231,087USD | — | — |
| Unclassified Equity | 452,315,000USD | 372,418,000USD | 365,519,605USD | 357,700,357USD | 350,963,230USD | 337,692,264USD | 283,068,183USD | 191,452,944USD |
| Intangible Assets | — | 92,000USD | 200,000USD | 222,100USD | 164,000USD | 318,900USD | 467,247USD | 391,872USD |
| Other Assets | — | — | 1USD | 1,930,753USD | 2,026,787USD | -100USD | 494,929USD | 2,919,716USD |
| Non Current Liabilities Other | — | — | 30,000,000USD | — | — | 61,200USD | 286,562USD | — |
| Good Will | — | — | — | -39,091USD | -96,034USD | 100USD | -247USD | — |
| Net Receivables | — | — | — | 261,191USD | — | 141,763USD | 1,131,146USD | 600,104USD |
| Net Tangible Assets | — | — | — | 132,272,563USD | 179,746,435USD | 43,312,753USD | 69,556,306USD | 38,413,273USD |
| Deferred Long Term Liab | — | — | — | — | — | 10,169,887USD | — | — |
| Other Liab | — | — | — | — | — | 10,231,087USD | 286,562USD | — |
| Current Deferred Revenue | — | — | — | — | — | 2,212,892USD | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow YTD
| Metric | Q2 20262026-06-30 · USD |
|---|---|
| Depreciation | 51,000USD |
| Stock Based Compensation | 2,477,000USD |
| Change To Liabilities | -1,754,000USD |
| Change In Working Capital | -1,665,000USD |
| Operating Cash Flow | -31,493,000USD |
| Net Investments | -80,790,000USD |
| Investing Cash Flow | -80,790,000USD |
| Financing Cash Flow | 110,583,000USD |
| Effect Of Forex Changes On Cash | -126,000USD |
| Change In Cash | -1,826,000USD |
| End Cash Flow | 13,258,000USD |
| Source | DisclosureDeterministicFinal |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -16,988,000USD | 9,663,000USD | -12,158,000USD | -4,684,000USD | -10,235,000USD | -9,253,000USD | -14,006,000USD | 8,521,000USD |
| Depreciation | 35,000USD | 17,000USD | 17,000USD | 99,000USD | 141,000USD | 147,000USD | 169,000USD | 148,000USD |
| Stock Based Compensation | 1,046,000USD | 1,195,000USD | 1,109,000USD | 1,219,000USD | 1,284,000USD | 1,260,000USD | 1,308,000USD | 1,740,000USD |
| Other Non Cash Items | 722,000USD | -21,417,000USD | 960,000USD | -164,000USD | -167,000USD | -49,000USD | -733,000USD | -27,112,000USD |
| Change In Working Capital | 2,332,000USD | 134,000USD | -1,691,000USD | -1,244,000USD | -1,303,000USD | -853,000USD | -1,745,000USD | 4,187,999USD |
| Total Cash From Operating Activities | -13,899,000USD | -10,408,000USD | -12,872,000USD | -4,774,000USD | -10,280,000USD | -10,008,000USD | -15,007,000USD | -14,255,000USD |
| Capital Expenditures | 0USD | 0USD | 0USD | 0USD | -22,000USD | -22,000USD | -4,000USD | -34,000USD |
| Free Cash Flow | -13,899,000USD | -10,408,000USD | -12,872,000USD | -4,774,000USD | -10,280,000USD | -10,030,000USD | -15,003,000USD | -14,289,000USD |
| Investments | 5,950,000USD | -72,062,000USD | 5,053,000USD | 12,053,000USD | 5,102,000USD | 21,292,000USD | 292,000USD | 12,822,000USD |
| Total Cashflows From Investing Activities | 5,950,000USD | -72,062,000USD | 5,053,000USD | 12,053,000USD | 5,102,000USD | 21,292,000USD | 292,000USD | 12,822,000USD |
| Total Cash From Financing Activities | 88,982,000USD | 75,179,000USD | 15,000USD | 0USD | 13,000USD | 0USD | 38,000USD | 356,000USD |
| Issuance Of Capital Stock | 62,169,000USD | — | — | — | 0USD | — | — | — |
| Change In Cash | 80,911,000USD | -7,458,000USD | -7,804,000USD | 7,279,000USD | -5,165,000USD | 11,284,000USD | -14,677,000USD | -1,078,000USD |
| Begin Period Cash Flow | 13,153,000USD | 22,542,000USD | 28,415,000USD | 23,067,000USD | 28,232,000USD | 15,017,000USD | 29,694,000USD | 30,772,000USD |
| End Period Cash Flow | 94,064,000USD | 15,084,000USD | 20,611,000USD | 30,346,000USD | 23,067,000USD | 26,301,000USD | 15,017,000USD | 29,694,000USD |
| Unclassified Operating Cash Flow | -1,046,000USD | — | -1,109,000USD | — | — | -1,260,000USD | — | -1,739,999USD |
| Unclassified Financing Cash Flow | 26,813,000USD | — | — | — | — | — | — | — |
| Other Cashflows From Financing Activities | — | 75,179,000USD | 15,000USD | — | 13,000USD | — | 38,000USD | 356,000USD |
| Other Cashflows From Investing Activities | — | — | — | — | 27,000USD | 1,000USD | — | -116,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -17,414,000USD | -26,433,000USD | -52,338,959USD | -54,169,029USD | 119,839,261USD | -81,035,576USD | -60,461,243USD | -51,979,610USD |
| Depreciation | 273,000USD | 613,000USD | 1,596,575USD | 1,381,605USD | 237,000USD | 306,848USD | 255,002USD | 141,733USD |
| Stock Based Compensation | 4,807,000USD | 6,276,000USD | 7,285,192USD | 6,556,686USD | 5,054,457USD | 7,525,354USD | 5,205,792USD | 7,063,941USD |
| Other Non Cash Items | -21,896,000USD | -36,262,000USD | -4,709,273USD | -764,939USD | 15,349,859USD | -199,408USD | -29,633USD | -1,240USD |
| Change In Working Capital | -4,104,000USD | -150,000USD | 2,385,540USD | -8,231,450USD | -16,814,447USD | 21,818,868USD | 3,939,460USD | -787,914USD |
| Total Cash From Operating Activities | -38,334,000USD | -55,956,000USD | -45,780,925USD | -55,227,127USD | 118,611,673USD | -51,583,914USD | -51,090,622USD | -45,558,480USD |
| Capital Expenditures | 0USD | -71,000USD | -137,455USD | -1,418,776USD | -184,013USD | -390,680USD | -244,045USD | -352,019USD |
| Free Cash Flow | -38,334,000USD | -56,027,000USD | -45,918,380USD | -56,645,903USD | 118,427,660USD | -51,974,594USD | -51,334,667USD | -45,910,499USD |
| Investments | -49,854,000USD | 54,594,000USD | 41,766,063USD | -85,464,441USD | -1,631,992USD | 35,038,908USD | -29,797,004USD | -5,011,623USD |
| Total Cashflows From Investing Activities | -49,854,000USD | 54,594,000USD | -2,580,605USD | -87,883,217USD | -1,821,400USD | 34,648,228USD | -30,041,049USD | -5,363,642USD |
| Total Cash From Financing Activities | 75,207,000USD | 622,000USD | 30,535,201USD | 180,658USD | 904,082USD | 47,072,472USD | 86,539,197USD | 286,140USD |
| Issuance Of Capital Stock | 75,116,000USD | 0USD | — | — | -221,065USD | 46,731,435USD | 86,407,302USD | 0USD |
| Change In Cash | -13,148,000USD | -740,000USD | -17,826,329USD | -142,929,686USD | 115,763,602USD | 30,136,786USD | 5,407,526USD | -50,635,982USD |
| Begin Period Cash Flow | 28,232,000USD | 28,972,000USD | 46,798,599USD | 189,728,285USD | 72,033,930USD | 41,897,144USD | 36,489,618USD | 87,125,600USD |
| End Period Cash Flow | 15,084,000USD | 28,232,000USD | 28,972,270USD | 46,798,599USD | 187,797,532USD | 72,033,930USD | 41,897,144USD | 36,489,618USD |
| Other Cashflows From Financing Activities | 75,207,000USD | 622,000USD | 30,535,201USD | 180,658USD | -21,314USD | 341,037USD | 131,895USD | 286,140USD |
| Unclassified Financing Cash Flow | -75,116,000USD | — | — | — | — | — | 22,154,671USD | — |
| Other Cashflows From Investing Activities | — | -89,000USD | -97,147USD | -1,000,000USD | -5,400,000USD | -263,440USD | -186,889USD | -318,148USD |
| Unclassified Investing Cash Flow | — | — | -44,112,066USD | — | 5,394,605USD | — | — | — |
| Change To Liabilities | — | — | — | -8,340,742USD | -17,473,884USD | 14,716,495USD | 1,821,257USD | 2,743,263USD |
| Sale Purchase Of Stock | — | — | — | 180,658USD | 904,082USD | 47,072,472USD | 64,252,631USD | 286,140USD |
| Cash And Cash Equivalents Changes | — | — | — | -142,929,686USD | 117,694,355USD | 30,136,786USD | 5,407,526USD | -50,635,982USD |
| Change To Account Receivables | — | — | — | — | 141,763USD | 989,383USD | -531,042USD | — |
| Change To Inventory | — | — | — | — | -141,763USD | -989,383USD | 531,042USD | — |
| Unclassified Operating Cash Flow | — | — | — | — | -5,054,457USD | — | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
| Period | Dimension | Business / region | Revenue | Currency | Source |
|---|---|---|---|---|---|
| FY 2022Yearly · 2022-12-31 | Product | License | 1,502,748 | USD | 0001628280-23-007648 |
| FY 2022Yearly · 2022-12-31 | Product | Related Party | 0 | USD | 0001628280-23-007648 |
| Q3 2022Quarterly · 2022-09-30 | Product | License | 11,102 | USD | 0001628280-22-028772 |
| Q3 2022Quarterly · 2022-09-30 | Product | Related Party | 0 | USD | 0001628280-22-028772 |
| Q1 2022Quarterly · 2022-03-31 | Product | License | 1,445,366 | USD | 0000950170-22-008739 |
| Q1 2022Quarterly · 2022-03-31 | Product | Related Party | 0 | USD | 0000950170-22-008739 |
| FY 2021Yearly · 2021-12-31 | Product | License | 12,382,779 | USD | 0001628280-23-007648 |
| FY 2021Yearly · 2021-12-31 | Product | Related Party | 196,000,000 | USD | 0001628280-23-007648 |
| Q1 2021Quarterly · 2021-03-31 | Product | License | 12,382,779 | USD | 0000950170-22-008739 |
| Q1 2021Quarterly · 2021-03-31 | Product | Related Party | 196,000,000 | USD | 0000950170-22-008739 |
| FY 2020Yearly · 2020-12-31 | Product | License | 12,617,221 | USD | 0000950170-22-003668 |
| FY 2020Yearly · 2020-12-31 | Product | Related Party | 0 | USD | 0000950170-22-003668 |
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.